NIPT in a clinical setting: An analysis of uptake in the first months of clinical availability

Journal of Genetic Counseling

Volumn 23, Issue 1, 2014, Pages 72-78

  Taylor, Joanne B ^a   Chock, Valerie Y ^b   Hudgins, Louanne ^a,c  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Cell free fetal DNA; NIPT; Prenatal genetic counseling; Prenatal screening; Uptake

Indexed keywords

ARTICLE; FEMALE; HUMAN; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; UTILIZATION REVIEW;

FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 84896767667     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9609-z     Document Type: Article

References (19)

1. ACOG Committee. (2007). ACOG Committee Opinion No. 88: invasive prenatal testing for aneuploidy. Obstetrics and Gynecology, 110(6), 1459-1467.
2. ACOG Committee. (2012). ACOG Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology, 120(6), 1532-1534.
3. Bianchi, D. W.; Platt, L. D.; Goldberg, J. D. et al. (2012). Genome-Wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology 119(5).
4. Biba, E. (2012). This simple blood test reveals birth defects - and the future of pregnancy. Retrieved 24 December 2012, from http://www.wired.com/ wiredscience/2012/12/ff-prenatal-testesting/all/
5. Finning, K.; & Chitty, L. (2008). Non-invasive fetal sex determination: Impact on clinical practice. Seminars in Fetal and Neonatal Medicine, 13(2), 69-75.
6. Green, J. M.; Hewison, J.; Bekker, H. L.; Bryant, L. D.; & Cuckle, H. S. (2004). Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technology Assessment, 8(33), 1-124.
7. Hall, A.; Bostanci, A.; & Wright, C. F. (2010). Non-Invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics, 13(4), 246-255.
8. Hawkins, A.; Stenzel, A.; Taylor, J. et al. (2012) Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities. Journal of Genetic Counseling Sep 23
9. Hyett, J. A.; Gardener, G.; Stojilkovic-Mikic, T.; et al. (2005). Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenatal Diagnosis, 25(12), 1111-1116.
10. Kagan, K. O.; Wright, D.; Baker, A.; et al. (2008). Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound in Obstetrics & Gynecology, 31, 618-624.
11. Kooij, L.; Tymstra, T.; & van den Berg, P. (2009). The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenatal Diagnosis, 29, 164-168.
12. Lewis, C.; Hill, M.; Skirton, H.; et al. (2012). Fetal sex determination using cell-free fetal DNA: service users' experiences of and preferences for service delivery. Prenatal Diagnosis, 32, 735-741.
13. Mujezinovic, F.; & Alfirevic, Z. (2007). Procedure-related complications of amniocentesis and chorinic villous sampling: a systematic review. Obstetrics and Gynecology, 110, 687-694.
14. Nicolaides, K. H.; Syngelaki, A.; Ashoor, G.; et al. (2012). Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. American Journal of Obstetrics and Gynecology, 207(5), 374.e1-6.
15. Norton, M. E.; Brar, H.; Weiss, J.; et al. (2012). Non-Invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. American Journal of Obstetrics and Gynecology, 207(2), 137.e1-8.
16. Palomaki, G. E.; Kloza, E. M.; Lambert-Messerlian, G. M.; et al. (2011). DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine, 13(11), 913.
17. Picone, O.; Senat, M. V.; Rosenblatt, J.; et al. (2008). Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Fetal Diagnosis and Therapy, 23(1), 30-35. Epub 2007 Oct 9.
18. Sapp, J. C.; Hull, S. C.; Duffer, S.; et al. (2010). Ambivalence toward undergoing invasive prenatal testing: an exploration of its origins. Prenatal Diagnosis, 30(1), 77-82.
19. Tischler, R.; Hudgins, L.; Blumenfeld, Y. J.; et al. (2011). Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenatal Diagnosis, 31(13), 1292-1299.